Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for glutathione root_names_name in Any Name (approximate match)

Showing 1021 - 1030 of 1596 results

First page
Previous page
Next page
Next page

NOFAZINLIMAB

42T48Q7A6O

Subunit 1 (442) Similarity Search Subunit 2 (442) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (442) Similarity Search Subunit 2 (442) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT04194775: Phase 3 Interventional Active, not recruiting Hepatocellular Carcinoma

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04194775

Class:

PROTEIN

Disitamab

474FJM6Y9C

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (212) Similarity Search Subunit 4 (212) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (212) Similarity Search Subunit 4 (212) Similarity Search

Status:

Investigational

Source:

INN:disitamab [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/474FJM6Y9C

Class:

PROTEIN

SEMZUVOLIMAB

4180O0RM6K

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT04406727: Phase 3 Interventional Not yet recruiting HIV-1 Infection

(2023)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04406727

Class:

PROTEIN

ALSEVALIMAB

U8LYN0Y118

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03514121: Early Phase 1 Interventional Terminated Breast Cancer

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03514121

Class:

PROTEIN

Luveltamab Tazide

KDY94MAQ0U

Subunit 1 (455) Similarity Search Subunit 2 (455) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (455) Similarity Search Subunit 2 (455) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

INN:luveltamab tazide [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/KDY94MAQ0U

Class:

PROTEIN

MELRILIMAB

26C72EGQ3G

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03207243: Phase 2 Interventional Completed Asthma

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03207243

Class:

PROTEIN

EPRATUZUMAB

3062P60MH9

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT01802814: Phase 3 Interventional Completed Acute Lymphoblastic Leukemia (ALL)

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01802814

Class:

PROTEIN

AVIZAKIMAB

4H3BBE5WVK

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03371251: Phase 1/Phase 2 Interventional Completed Systemic Lupus Erythematosus

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03371251

Class:

PROTEIN

GRISNILIMAB SETARITOX

ES6SG61M8L

Subunit 1 (453) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (453) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

INN:grisnilimab setaritox [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/ES6SG61M8L

Class:

PROTEIN

Exlinkibart

23C7TO9S06

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:exlinkibart [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/23C7TO9S06

Class:

PROTEIN

Protein

Protein

Protein

Protein

Protein

Luveltamab Tazide

Protein

Protein

Protein

Protein

GRISNILIMAB SETARITOX

Protein

Showing 1021 - 1030 of 1596 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1